scholarly article | Q13442814 |
P50 | author | Francesc X. Sureda | Q42172321 |
Esther Gratacòs-Batlle | Q59553089 | ||
Santiago Vazquez | Q61159610 | ||
Rosana Leiva | Q119833275 | ||
P2093 | author name string | Jon W Johnson | |
David Soto | |||
Andreea L Turcu | |||
Lara León-García | |||
Matthew B Phillips | |||
P2860 | cites work | Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond | Q22251042 |
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults | Q24558984 | ||
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis | Q26861399 | ||
Molecular bases of NMDA receptor subtype-dependent properties | Q27012689 | ||
Crystal structure of a heterotetrameric NMDA receptor ion channel | Q27684006 | ||
NMDA receptor structures reveal subunit arrangement and pore architecture | Q27684638 | ||
Activation of NMDA receptors and the mechanism of inhibition by ifenprodil | Q27704785 | ||
The glutamate receptor ion channels | Q28137916 | ||
The chemical biology of clinically tolerated NMDA receptor antagonists | Q28248958 | ||
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs | Q28270170 | ||
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists | Q28287381 | ||
Glutamate receptor ion channels: structure, regulation, and function | Q28290774 | ||
Mechanism of NMDA Receptor Inhibition and Activation | Q30774134 | ||
Azapropellanes with anti-influenza a virus activity. | Q33889072 | ||
NMDA receptor subunits: diversity, development and disease | Q33950711 | ||
Glutamate as a neurotransmitter in the healthy brain | Q34048502 | ||
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders | Q34138025 | ||
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? | Q34212543 | ||
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. | Q34407523 | ||
Extrasynaptic NMDA receptor involvement in central nervous system disorders | Q34415681 | ||
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function | Q34629359 | ||
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease | Q34651972 | ||
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization | Q34668783 | ||
Pathologically activated therapeutics for neuroprotection | Q34691239 | ||
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. | Q34756031 | ||
Recent insights into the mode of action of memantine and ketamine | Q35054539 | ||
Structure and function of glutamate receptor ion channels | Q35672501 | ||
Glutamate in CNS disorders as a target for drug development: an update | Q35992523 | ||
Synaptic NMDA receptors mediate hypoxic excitotoxic death | Q35993627 | ||
Mechanism of action of memantine | Q36348056 | ||
Ionic Blockage of Sodium Channels in Nerve | Q36388606 | ||
NMDA receptors in clinical neurology: excitatory times ahead | Q36660216 | ||
Amantadine: the journey from fighting flu to treating Parkinson disease. | Q37999777 | ||
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections | Q38014513 | ||
NMDA receptors in nervous system diseases. | Q38098824 | ||
NMDA receptors and memory encoding | Q38102828 | ||
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors. | Q38131223 | ||
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement | Q38666754 | ||
Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applications | Q38975453 | ||
NMDA receptors: linking physiological output to biophysical operation. | Q39182931 | ||
Classics in Chemical Neuroscience: Memantine | Q39454363 | ||
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors | Q39563266 | ||
N-methyl-D-aspartic acid receptor structure and function | Q40674725 | ||
Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation. | Q41502069 | ||
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. | Q41509275 | ||
AMPAR interacting protein CPT1C enhances surface expression of GluA1-containing receptors. | Q41889628 | ||
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus | Q42103503 | ||
Key binding interactions for memantine in the NMDA receptor. | Q42565522 | ||
Neramexane: a moderate-affinity NMDA receptor channel blocker: new prospects and indications | Q42637057 | ||
Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage | Q44395839 | ||
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs | Q46292312 | ||
Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization. | Q47255869 | ||
Trapping channel block of NMDA-activated responses by amantadine and memantine | Q73271990 | ||
Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block | Q77299364 | ||
Novel benzopolycyclic amines with NMDA receptor antagonist activity | Q87607803 | ||
P433 | issue | 11 | |
P304 | page(s) | 2722-2730 | |
P577 | publication date | 2018-06-01 | |
P1433 | published in | ACS Chemical Neuroscience | Q2819059 |
P1476 | title | Pharmacological and Electrophysiological Characterization of Novel NMDA Receptor Antagonists | |
P478 | volume | 9 |
Q92132940 | Dual action of amitriptyline on NMDA receptors: enhancement of Ca-dependent desensitization and trapping channel block | cites work | P2860 |
Search more.